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ABSTRACT
Background: Induction of ovulation is a key procedure for horse assisted reproduction technologies, such as for artificial 
insemination (AI) and embryo transfer. The application of hCG remains as the primary ovulation-inducing agent for horse 
assisted reproduction, but alternatives are in demand to avoid its adverse effects, such as loss of ovulation-inducing ef-
ficiency over multiple applications by hCC-antibody production. Despite reports on alternative ovulation-inducing agents, 
pair-wise comparisons of such agents under similar conditions have been limited. Under such scenario, the work was aimed 
to determine the efficiency of both hCG and Buserelin at inducing ovulation in Mangalarga Marchador mares raised in the 
Northeast of Brazil under an AI program.
Materials, Methods & Results: Mares were initially selected based on their reproductive performance, the absence of 
clinical-reproductive alterations and adequate body condition score. Mares in diestrus were randomly distributed in three 
experimental conditions, received 5 mg of Dinoprost and were monitored daily for estrus detection. After estrus detection, 
ovaries were monitored by ultrasonography, in 12-h intervals, until the follicle reached 35 mm. At this time-point, ovula-
tion was induced with 0.042 mg of Buserelin endovenously, with 3,000 IU hCG by an intramuscular shot, and control 
mares received 2 mL of saline solution, also by an intramuscular shot. Both hCG and Buserelin displayed similar efficien-
cies (P > 0.05) for induction of ovulation and that both agents were effective (P < 0.05) for such purpose, since greater 
percentages (P < 0.05) of induction on mares treated from those of the control. Moreover, the total number of ovulations 
in mares treated at the end of the experiment was not different (P > 0.05) from those found in the Control. All ovulations 
occurred within a 72-h period after treatment. It can be observed that in mares treated with hCG or Buserelin, ovulations 
occurred both in more mares (P < 0.05) and at earlier time-points than mares from the control. It is also possible to note 
that pregnancy was not different (P > 0.05) between hCG and Buserelin groups, and that pregnancy of mares treated with 
ovulation-inducing factors was similar to the control. 
Discussion: The majority of ovulations in mares occurred within initial 48-h after treatment for both hCG and GnRH, 
suggesting a similar potential for horse assisted reproduction. Both hCG and Buserelin are two commonly used agents for 
induction of ovulation in mares. As described here, the majority of ovulations occurred within initial 48-h after treatment, 
a fact which can be attributed to hCG and GnRH activity, since it can happen in intervals from 36 to 48-h after treatment. 
Pregnancy rates did not differ among groups. These results are under the working hypothesis that hCG and Buserelin would 
display similar efficiencies on pregnancy rates. Despite the understanding of hCG activity on induction of ovulation due to 
its high specificity toward LH receptors and results from a direct effect on diminishing estradiol concentration, increasing 
LH, and further inducing ovulation within 48-h after treatment. In contrast, Buserelin has a similar functional property but 
acts upon LH synthesis and its release. In conclusion, ovulation in mares can be induced with both hCG and Buserelin, 
and both ovulation-inducing agents do not affect pregnancy rates. 
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INTRODUCTION
The duration of the estrogenic phase in horses 
does not allow to predict the exact moment of ovula-
tion [14], and follicle growth monitoring is required 
for ovulation assessment [3,15]. Therefore, ovulation-
inducing agents are investigated aiming to increase 
both artificial insemination (AI) and embryo transfer 
efficiencies [3,27,29].
The hCG was the first ovulation-inducing agent 
and remains as the most widely used in mares [30]. 
Its structure resembles the LH protein, a fact which 
has suggested that its ovulation-inducing properties 
result from a direct effect on diminishing estradiol 
concentration, increasing LH, and ovulation within 
48-h after treatment [3,16,40]. It is advisable that 
when the follicle reaches 35 mm, hCG should be used 
for induction of ovulation [7]. However, there is some 
controversy that its usage by repeated means may affect 
mare fertility [5,12,17,21,37]. This detrimental effect 
may be caused by the formation of antibodies against 
hCG [12,21,33].
The GnRH is synthesized in the hypothalamus, 
and its release in pulses stimulates the synthesis and 
release of both LH and FSH by the anterior pituitary 
[22]. The GnRH is a natural ovulation-inducing fac-
tor, although it has a short half-life [34]. The synthetic 
analogs of GnRH such as Buserelin [6,17], Deslorelin 
[1,3,4], and Histrelin [26,30,39], have greater potency 
and longer half-life confers greater structural and meta-
bolic stability than its natural form [24]. Collectively, 
all these compounds have been considered as capable 
of inducing ovulation in mares. Thus, the work aimed 
to determine the efficiency of both hCG and Buserelin 
at inducing ovulation in Mangalarga Marchador mares 
raised in the Northeast of Brazil under an AI program.
MATERIALS AND METHODS
Experimental location
The experiment was conducted in Limoeiro, 
Pernambuco State, Brazil. The farm is located in the 
following geographic coordinates, 7o 52’ 29’’ S of 
latitude and 35o 27’ 01’’ W of longitude. The mean an-
nual temperature is 24oC, and quantum of rain reaches 
1,248 mm3.
Animal selection
Mares selected for the experiment as donors 
and recipients were pluriparous, non-lactating and of 
the Mangalarga Machador breed, with age ranging 
from 5 to 15 years and body weight from 450 to 550 
kg. Mares were subject to a semi-extensive pasturing 
system, thus maintained in cultivated pastures (Digi-
taria decumbes) and had free access to mineralized 
salt (Suprafós 73®)1 and water. Moreover, mares were 
further supplemented with hay (Cynodon spp.), Alfalfa 
(Medicago sativa) and 4 kg commercial palletized 
horse food (Corcelina®)2.
Mare selection was performed by body condi-
tion score evaluation, that varied from 5 to 7, in a 1 to 9 
scale, as established by others [18]. Their selection also 
considered the reproductive performance, clinical ex-
ams, and gynecologic examination by ultrasonography 
(Aquila Pro®)3, equipped with a linear multifrequency 
transducers (6 and 8 MHz) for identification of the 
presence of possible endometrial alterations that may 
affect fertility, as previously suggested [38].
Animal management
Mares in diestrus (n = 60) were randomly and 
equally distributed into three experimental condi-
tions, received 5 mg of Dinoprost (Lutalyse®)4 by an 
intramuscular (IM) shot. After the application of this 
luteolytic agent, mares were observed daily for estrus 
detection. Upon estrus detection, ovaries were moni-
tored by ultrasonography in 12-h intervals, until the 
follicle reached 35 mm when ovulation was induced 
by candidate inducers. 
One group of mares (n = 20) received 0.042 
mg Buserelin acetate (Conceptal®)5 endovenously, 
another group (n = 20) was treated with 3,000 IU hCG 
(Vetecor®)6 by IM shot, and the control (n = 20) was 
treated with 2 mL of saline solution (0.9 %, NaCl)7 
by IM shot. The ultrasonography monitoring was 
performed until ovulation detection. Ovulations were 
considered induced when detected until day 3 (72-h) 
after its induction. 
Mares were subject to AI at 48-h intervals 
until ovulation using cooled semen (4oC) at the con-
centration of 500 x 106 viable sperm cells. Pregnancy 
diagnosis was performed on days 30 and 60 after AI, 
according to previous work [32].
Statistical analysis
The statistical analysis of binomial data was 
presented as percentages were performed by the chi-
square test with Yates correction [31]. The significance 
level was 5%.
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RESULTS
The Table 1 shows that hCG and Buserelin 
display the same efficiency (P > 0.05) for induction 
of ovulation and that both substances are effective 
(P < 0.05) for this purpose, since greater percentages 
(P < 0.05) of induction on mares treated from those of 
the control. However, the total number of ovulations 
of mares treated at the end of the experiment was not 
different (P > 0.05) from those found in the Control.
The Figure 1A contains the distribution of ovu-
lations that occurred until 72-h after treatment. It can 
be noted that in mares treated with hCG or Buserelin, 
ovulations occurred both in more mares (P < 0.05) 
and at earlier time-points than mares from the control. 
Figure 1B shows that pregnancy was not different 
(P > 0.05) between hCG and Buserelin groups, and that 
pregnancy of mares treated with ovulation-inducing 
factors was similar to the control.
Figure 1. Distribution of ovulations within 72 h after treatment with ovulation-inducing agents (A) and total pregnancy after artificial insemination (B). 
Different letters on same time-period indicate statistical significance (P < 0.05).









0 - 3 20/20 (100.0)A 18/20 (90.0)A 6/20 (30.0)B 
> 3 - 2/20 (10.0)A 12/20 (60.0)B
Total 20/20 (100.0)A 20/20 (100.0)A 18/20 (90.0)B
Different letters on same line indicate statistical significance (P < 0.05). 
DISCUSSION
Both hCG and Buserelin continue as two com-
monly used agents for induction of ovulation in mares 
[26]. As described here, the majority of ovulations oc-
curred within initial 48-h after treatment, a fact which 
can be attributed to hCG and GnRH activity, since it can 
happen in intervals from 36 to 48-h after treatment [13].
Except for one reference [2] that obtained 
100% ovulation rate in mares treated with hCG, other 
reports [8,26] found similar percentages to those de-
scribed above. It is possible that divergences among 
results of some authors can be attributed to the period 
of the breeding season, since such ovulation-inducing 
agents are less efficient at the beginning and the end 
of the aforementioned season, possibly due to shorter 
exposure to sunlight [5].
According to Wilson et al. [40], similarities 
in the molecular structure and binding of hCG to LH 
receptors has suggested that its ovulation-inducing 
properties in mares result from a direct effect that mim-
ics the mechanisms that increase LH concentration. 
Gunther et al. [16] verified that hCG reduces estradiol 
and increases LH concentrations, thus inducing ovu-
lation after 48-h of treatment. This fact explains why 
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the majority of mares treated with hCG, as described 
above, have ovulated within 25 to 48-h after receiving 
this gonadotropin. It may be possible that ovulations 
that occurred before this period did not correspond to 
the hormone therapy. This fact is based on the fact that 
as ovulations within initial 24-h after treatment did not 
happen due to this ovulation-inducing agent, are spon-
taneous ovulations determined by the LH endogenous 
peak, as previously suggested [21].
The initial usage of natural GnRH to induce 
ovulation did not yield exciting results, due to its low 
potency and short half-life [34]. The advent of its 
synthetic analogs, with greater activity and prolonged 
half-life, the perspective of its application changed 
completely. In Brazil, Deslorelin is currently being 
used for induction of single, or more particularly, 
multiple ovulations [3,4,25,35,36,38]. As described 
here, Buserelin was considered effective since induced 
ovulation frequency did not differ from the obtained 
with hCG, and were also not different from those 
reported by authors using this agent [6,9,26] or other 
synthetic analogs [2,10]. 
The knowledge of ovulation-inducing agents 
commercially available, mare individual evaluation and 
adequate management practices are fundamental for suc-
cessful hormone therapy [13]. The results for induction of 
ovulation described here can be credited to several factors, 
in particular to some aspects related to the mare, such as 
adequate body condition score, estrus cycle regularity, 
and absence of previous reproductive problems. Another 
element that also contributed to such results was to ad-
minister both ovulation-inducing agents at the moment 
where follicles had reached at least 35 mm [28]. 
Pregnancy rates did not differ from those 
reported by several groups [11,19,20,23]. Moreover, 
these pregnancy results are in agreement with the initial 
hypothesis that hCG and Buserelin would show similar 
efficiencies. Despite the knowledge on hCG for induc-
tion of ovulation due to its high specificity toward the 
LH receptors, Buserelin is responsible for stimulating 
LH synthesis and its release. Therefore, despite in an 
indirect fashion, it exerts a relevant effect on the induc-
tion of ovulation. Moreover, the results described here 
can also be due to mare selection based on the repro-
ductive performance, absence of clinical-reproductive 
alterations, adequate body condition score, regularity 
in cyclicity, and estrus duration.
CONCLUSIONS
In conclusion, ovulation in mares can be 
induced with both hCG and Buserelin, and both ovu-
lation-inducing agents do not affect pregnancy rates.
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